Cargando…
DOT1L-HES6 fusion drives androgen independent growth in prostate cancer
Autores principales: | Annala, Matti, Kivinummi, Kati, Leinonen, Katri, Tuominen, Joonas, Zhang, Wei, Visakorpi, Tapio, Nykter, Matti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197859/ https://www.ncbi.nlm.nih.gov/pubmed/25006183 http://dx.doi.org/10.15252/emmm.201404210 |
Ejemplares similares
-
The expression of AURKA is androgen regulated in castration-resistant prostate cancer
por: Kivinummi, Kati, et al.
Publicado: (2017) -
Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
por: Kallio, Heini M. L., et al.
Publicado: (2018) -
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
por: Latonen, Leena, et al.
Publicado: (2018) -
Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
por: Bova, G. Steven, et al.
Publicado: (2016) -
Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer
por: Annala, Matti, et al.
Publicado: (2015)